Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Show all lipids with this classification Show all lipids assigned to this classification.
Show only primary classification Show only those lipids which have been assigned to this class as the primary classification.
Show only secondary classifications Show only lipids which have this functionality but are not primarily assigned to this class.

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA13000001 Lanceolitol A1 D-myo-inositol-2-O-dodecanoyl-1-O-beta-D-xylopyranoside C23H42O11 494.272716
LMFA13000003 Lanceolitol A3 D-myo-inositol-2-O-14-methylpentadecanoyl-1-O-beta-D-xylopyranoside C27H50O11 550.335316
LMFA13000004 Lanceolitol A4 D-myo-inositol-2-O-10-methylpentadecanoyl-1-O-beta-D-xylopyranoside C27H50O11 550.335316
LMFA13000005 Lanceolitol A5 D-myo-inositol-2-O-9-methylheptadecanoyl-1-O-beta-D-xylopyranoside C29H54O11 578.366616
LMFA13000006 Lanceolitol A6 D-myo-inositol-2-O-16-methylheptadecanoyl-1-O-beta-D-xylopyranoside C29H54O11 578.366616
LMFA13000007 Lanceolitol A7 D-myo-inositol-2-O-eicosanoyl-1-O-beta-D-xylopyranoside C31H58O11 606.397916
LMFA13000008 Lanceolitol B1 D-myo-inositol-2-O-dodecanoyl-1-O-beta-D-glucopyranoside C24H44O12 524.283281
LMFA13000010 Lanceolitol B3 D-myo-inositol-2-O-14-methylpentadecanoyl-1-O-beta-D-glucopyranoside C28H52O12 580.345881
LMFA13000011 Lanceolitol B4 D-myo-inositol-2-O-10-methylpentadecanoyl-1-O-beta-D-glucopyranoside C28H52O12 580.345881
LMFA05000063 6-[5]-ladderane-1-hexanol 6-[5]-ladderane-1-hexanol FOH 18:5 C18H28O 260.214015
LMFA13000012 Lanceolitol B5 D-myo-inositol-2-O-9-methylheptadecanoyl-1-O-beta-D-glucopyranoside C30H56O12 608.377181
LMFA13000013 Lanceolitol B6 D-myo-inositol-2-O-16-methylheptadecanoyl-1-O-beta-D-glucopyranoside C30H56O12 608.377181
LMFA13000014 Lanceolitol B7 D-myo-inositol-2-O-eicosanoyl-1-O-beta-D-glucopyranoside C32H60O12 636.408481
LMFA01170029 Octadecanedioic acid Octadecanedioic acid FA 18:1;O2 C18H34O4 314.245711
LMFA01170029 Octadecanedioic acid Octadecanedioic acid FA 18:1;O2 C18H34O4 314.245711
LMFA01030750 2,4,6-trimethyl-2,15-tetracosadienoic acid 2,4,6-trimethyl-2,15-tetracosadienoic acid FA 27:2 C27H50O2 406.381081
LMFA01030750 2,4,6-trimethyl-2,15-tetracosadienoic acid 2,4,6-trimethyl-2,15-tetracosadienoic acid FA 27:2 C27H50O2 406.381081
LMFA01030736 5,8,11,14-Octadecatetraynoic acid 5,8,11,14-Octadecatetraynoic acid FA 18:8 C18H20O2 268.146330
LMFA01030736 5,8,11,14-Octadecatetraynoic acid 5,8,11,14-Octadecatetraynoic acid FA 18:8 C18H20O2 268.146330
LMFA01170044 4E-Decenedioic acid 4E-Decenedioic acid FA 10:2;O2 C10H16O4 200.104860
LMFA01170044 4E-Decenedioic acid 4E-Decenedioic acid FA 10:2;O2 C10H16O4 200.104860
LMFA03010159 1a,1b-dihomo-15-deoxy-delta-12,14-PGD2 1a,1b-dihomo-9S-hydroxy-11-oxo-5Z,12E,14E-prostatrienoic acid FA 22:5;O2 C22H34O4 362.245711
LMFA02000033 2R-HOTrE 2R-hydroxy-9Z,12Z,15Z-octadecatrienoic acid FA 18:3;O C18H30O3 294.219496
LMFA02000033 2R-HOTrE 2R-hydroxy-9Z,12Z,15Z-octadecatrienoic acid FA 18:3;O C18H30O3 294.219496
LMFA02000033 2R-HOTrE 2R-hydroxy-9Z,12Z,15Z-octadecatrienoic acid FA 18:3;O C18H30O3 294.219496
LMFA04000026 (+/-)-8-HDoHE (+/-)-8-hydroxy-4Z,6E,10Z,13Z,16Z,19Z-docosahexaenoic acid FA 22:6;O C22H32O3 344.235146
LMFA04000026 (+/-)-8-HDoHE (+/-)-8-hydroxy-4Z,6E,10Z,13Z,16Z,19Z-docosahexaenoic acid FA 22:6;O C22H32O3 344.235146
LMFA04000026 (+/-)-8-HDoHE (+/-)-8-hydroxy-4Z,6E,10Z,13Z,16Z,19Z-docosahexaenoic acid FA 22:6;O C22H32O3 344.235146
LMFA07060021 3,5,7,9,11,13,15-heptaoxo-hexadecanoyl-[acp] 3,5,7,9,11,13,15-heptaoxo-hexadecanoyl-[acp]
LMFA02000046 alpha-12,13-DiHODE (+/-)-12,13-dihydroxy-9Z,15Z-octadecadienoic acid FA 18:2;O2 C18H32O4 312.230061
LMFA02000046 alpha-12,13-DiHODE (+/-)-12,13-dihydroxy-9Z,15Z-octadecadienoic acid FA 18:2;O2 C18H32O4 312.230061
LMFA02000046 alpha-12,13-DiHODE (+/-)-12,13-dihydroxy-9Z,15Z-octadecadienoic acid FA 18:2;O2 C18H32O4 312.230061
LMFA03010167 19R-hydroxy-PGB2 9-oxo-15S,19R-dihydroxy-5Z,8(12),13E-prostatrienoic acid FA 20:5;O3 C20H30O5 350.209326
LMFA01170061 2-hydroxy-2-butenedioic acid 2-hydroxy-2-butenedioic acid FA 4:2;O3 C4H4O5 132.005875
LMFA01170061 2-hydroxy-2-butenedioic acid 2-hydroxy-2-butenedioic acid FA 4:2;O3 C4H4O5 132.005875
LMFA01170061 2-hydroxy-2-butenedioic acid 2-hydroxy-2-butenedioic acid FA 4:2;O3 C4H4O5 132.005875
LMFA03030000 Thromboxanoic acid skeleton
LMFA05000078 15-methyl-1,2-eicosanediol 15-methyleicosane-1,2-diol FOH 21:0;O C21H44O2 328.334131
LMFA01050362 2S-hydroxylauric acid 2S-hydroxydodecanoic acid FA 12:0;O C12H24O3 216.172545
LMFA03050036 12S-HETrE 12S-hydroxy-8Z,10E,14Z-eicosatrienoic acid C20H34O3 322.250796
LMFA03050036 12S-HETrE 12S-hydroxy-8Z,10E,14Z-eicosatrienoic acid C20H34O3 322.250796
LMFA03050036 12S-HETrE 12S-hydroxy-8Z,10E,14Z-eicosatrienoic acid C20H34O3 322.250796
LMFA03080028 (+/-)14,15-EpETrE-d11 14,15-epoxy-5Z,8Z,11Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11 acid C20H21D11O3 331.304190
LMFA03080028 (+/-)14,15-EpETrE-d11 14,15-epoxy-5Z,8Z,11Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11 acid C20H21D11O3 331.304190
LMFA03080028 (+/-)14,15-EpETrE-d11 14,15-epoxy-5Z,8Z,11Z-eicosatrienoic-16,16,17,17,18,18,19,19,20,20,20-d11 acid C20H21D11O3 331.304190
LMFA07010357 SFE 16:2(4E,6Z)/2:0 4E,6Z-Hexadecadienyl acetate SFE 18:2 C18H32O2 280.240231
LMFA07010357 SFE 16:2(4E,6Z)/2:0 4E,6Z-Hexadecadienyl acetate SFE 18:2 C18H32O2 280.240231
LMFA01130006 3-methyl-thiopropionic acid 3-(methyl-sulfanyl)-propanoic acid C4H8O2S 120.024501
LMFA04040008 17(R)-Neuroprotectin D1 10R,17R-dihydroxy-4Z,7Z,11E,13E,15Z,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230061
LMFA04040008 17(R)-Neuroprotectin D1 10R,17R-dihydroxy-4Z,7Z,11E,13E,15Z,19Z-docosahexaenoic acid FA 22:6;O2 C22H32O4 360.230061